| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Mehmet Taskiran, Sacide Yildiz Taskiran, Gokhan Unal, Nuh Mehmet Bozkurt, Asuman Golgel. Vortioxetine improved schizophrenia-like behavioral deficits in a Poly I:C-induced maternal immune activation model of schizophrenia in rats. Fundamental & clinical pharmacology. 2024-07-04. PMID:38962906. |
vortioxetine improved schizophrenia-like behavioral deficits in a poly i:c-induced maternal immune activation model of schizophrenia in rats. |
2024-07-04 |
2024-07-10 |
rat |
| Aleksandr M Reznik, Timur S Syunyakov, Aleksandr V Mudrak, Nikolay B Zakharov, Zhanna B Popova, Anastasia N Khoroshilova, Ilona G Khurbatova, Alina M Saifulina, Anton M Eliseenko, Tatiana K Matvievskaya, Angelina N Khannanov. Treatment of Depression with Vortioxetine and Second Generation Antipsychotics During the Period of Remission Formation in Schizophrenia (Interim Data Analysis). Consortium psychiatricum. vol 4. issue 1. 2024-01-19. PMID:38239568. |
treatment of depression with vortioxetine and second generation antipsychotics during the period of remission formation in schizophrenia (interim data analysis). |
2024-01-19 |
2024-01-21 |
Not clear |
| Greš Alen, Šagud Marina, Dickov Aleksandr. The effect of vortioxetine on anhedonia in patients with schizophrenia. International journal of psychiatry in medicine. 2023-08-30. PMID:37647498. |
the effect of vortioxetine on anhedonia in patients with schizophrenia. |
2023-08-30 |
2023-09-07 |
Not clear |
| Greš Alen, Šagud Marina, Dickov Aleksandr. The effect of vortioxetine on anhedonia in patients with schizophrenia. International journal of psychiatry in medicine. 2023-08-30. PMID:37647498. |
the purpose of this study was to examine the effects of vortioxetine on anhedonia in patients with schizophrenia. |
2023-08-30 |
2023-09-07 |
Not clear |
| Nuh Mehmet Bozkurt, Gokhan Una. Vortioxetine Improved Negative and Cognitive Symptoms of Schizophrenia in Subchronic MK-801 Induced Schizophrenia Model in Rats. Behavioural brain research. 2023-03-01. PMID:36858318. |
therefore, we investigated the potential beneficial effects of vortioxetine on behavioral and molecular deficits in the mk-801 model of schizophrenia in rats. |
2023-03-01 |
2023-08-14 |
rat |
| Nuh Mehmet Bozkurt, Gokhan Una. Vortioxetine Improved Negative and Cognitive Symptoms of Schizophrenia in Subchronic MK-801 Induced Schizophrenia Model in Rats. Behavioural brain research. 2023-03-01. PMID:36858318. |
vortioxetine improved negative and cognitive symptoms of schizophrenia in subchronic mk-801 induced schizophrenia model in rats. |
2023-03-01 |
2023-08-14 |
rat |
| Kouji Fukuyama, Eishi Motomura, Motohiro Okad. Therapeutic Potential and Limitation of Serotonin Type 7 Receptor Modulation. International journal of molecular sciences. vol 24. issue 3. 2023-02-11. PMID:36768393. |
to date, the initially expected rapid onset of antidepressant effects-in comparison with conventional antidepressants or mood-stabilising antipsychotics-due to 5-ht7 inhibition has not been observed with lurasidone and vortioxetine; however, several clinical studies suggest that 5-ht7 inhibition likely contributes to quality of life of patients with schizophrenia and mood disorders via the improvement of cognition. |
2023-02-11 |
2023-08-14 |
Not clear |
| Tathagata Biswas, Biswa Ranjan Mishra, Rajeev Ranjan, Rituparna Mait. Cognitive Improvements with Vortioxetine in Schizophrenia: A Case Report. Psychiatria Danubina. vol 34. issue 4. 2022-12-22. PMID:36548892. |
cognitive improvements with vortioxetine in schizophrenia: a case report. |
2022-12-22 |
2023-08-14 |
Not clear |
| Sofia Redaelli, Lilla Porffy, Ebenezer Oloyede, Olubanke Dzahini, Gabriella Lewis, Maria Lobo, Eromona Whiskey, Sukhi S Shergil. Vortioxetine as adjunctive therapy in the treatment of schizophrenia. Therapeutic advances in psychopharmacology. vol 12. 2022-07-14. PMID:35833056. |
vortioxetine as adjunctive therapy in the treatment of schizophrenia. |
2022-07-14 |
2023-08-14 |
Not clear |
| Sergio De Filippis, Ginevra Lombardozzi, Marta Matrone, Emanuela Amici, Giada Trovini, Filippo Perrini, Alessandro Di Giovanni, Valeria Giovanetti, Georgios D Kotzalidi. Differential response to three antidepressants in patients with major depressive episode who suffered Covid-19-related trauma. Current neuropharmacology. 2022-03-11. PMID:35272591. |
we compared responses to three different antidepressant drugs, i.e., vortioxetine, sertraline, and trazodone, in outpatients with mde during major depressive disorder (mdd), bipolar disorder (bd), or schizophrenia and related psychoses (ssopds) during two time periods, i.e., prior to suffering covid-19-related trauma and after suffering such trauma. |
2022-03-11 |
2023-08-13 |
Not clear |
| Ehsan Moazen-Zadeh, Samaneh Bayanati, Kimia Ziafat, Farzin Rezaei, Bita Mesgarpour, Shahin Akhondzade. Vortioxetine as adjunctive therapy to risperidone for treatment of patients with chronic schizophrenia: A randomised, double-blind, placebo-controlled clinical trial. Journal of psychopharmacology (Oxford, England). vol 34. issue 5. 2021-06-17. PMID:32122230. |
vortioxetine, a novel antidepressant, may be an interesting candidate for adjunctive therapy of schizophrenia. |
2021-06-17 |
2023-08-13 |
Not clear |
| Ehsan Moazen-Zadeh, Samaneh Bayanati, Kimia Ziafat, Farzin Rezaei, Bita Mesgarpour, Shahin Akhondzade. Vortioxetine as adjunctive therapy to risperidone for treatment of patients with chronic schizophrenia: A randomised, double-blind, placebo-controlled clinical trial. Journal of psychopharmacology (Oxford, England). vol 34. issue 5. 2021-06-17. PMID:32122230. |
vortioxetine as adjunctive therapy to risperidone for treatment of patients with chronic schizophrenia: a randomised, double-blind, placebo-controlled clinical trial. |
2021-06-17 |
2023-08-13 |
Not clear |
| Antonio Bruno, Rocco Antonio Zoccali, Giulia Maria Troili, Loredana Scala, Gianluca Pandolfo, Clemente Cedro, Carmela Mento, Vincenza Santoro, Edoardo Spina, Maria Rosaria Anna Muscatell. Vortioxetine on Cognition in Schizophrenia: A Pilot Study. Journal of clinical psychopharmacology. vol 40. issue 4. 2021-01-21. PMID:32639291. |
vortioxetine on cognition in schizophrenia: a pilot study. |
2021-01-21 |
2023-08-13 |
Not clear |